Ozempic, Wegovy, and Rybelsus are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound and Mounjaro are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.
(Table S3) Subgroup, sensitivity and specificity analyses based on the treated population Subgroup analyses were performed focusing on age, comorbidities such as hypertension and advanced CKD, and medication use (Fig
Root-Cause Treatment Lab work identifies insulin resistance, inflammation, thyroid issues, hormone imbalances and treats them alongside the medication
Clinical trials consistently show weight loss of 1520% or more with GLP-1s, compared to 510% with medications like Contrave, orlistat, and phentermine